Sign up for news & promotions:
P16 (Mouse and Human) Primary Antibody
| Item Information | ||
|---|---|---|
| Catalog # | Size/Concentration | Price |
| 20129 | 100μl | $393.00 |
| Specification | |
|---|---|
| Aliases | P16 |
| Product Order | P |
| Clone# | 2D9A12 |
| Entrez GeneID | 1029 |
| Formulation | Ascitic fluid containing 0.03% sodium azide. |
| Host | Mouse |
| Isotype | IgG2b |
| Immunogen | Purified recombinant fragment of P16 expressed in E. Coli. |
| Shipping Information | This product will ship in a box containing blue ice at a temperature of 4°C. Learn More |
| Species Reactivity | Human, Rat |
| Application | |
|---|---|
| ELISA | 1/10000 |
| IHC_P (Immunohistochemistry) | 1/200 - 1/1000 |
| WB (Western Blot) | 1/500 - 1/2000 |
| Sequence |
|---|
| N/A |
Images
Western Blot
Figure 1: Western blot analysis using P16 mouse mAb against truncated P16 recombinant protein.
Immunohistochemical analysis
Figure 2: Immunohistochemical analysis of paraffin-embedded rat liver tissue (A), human brain tissue (B) and brain tumor (C), showing nuclear localization using P16 mouse mAb with DAB staining.
Product Overview
| Description | The progression of cells through the cell cycle is regulated by a family of protein kinases known as cyclin-dependent kinases (Cdks). The sequential activation of individual members of this family and their consequent phosphorylation of critical substrates promotes orderly progression through the cell cycle. The cyclins function as differentially expressed positive regulators of Cdks. Negative regulators of the cycle include the p53-inducible 21 kDa WAF1/Cip1 protein designated p21, Kip1 p27 and p16. The complexes formed by Cdk4 and the D-type cyclins have been strongly implicated in the control of cell proliferation during the G1 phase. It has recently been shown that p16 binds to Cdk4 and inhibits the catalytic activity of the Cdk4/cyclin D complex. Moreover, the gene encoding p16 exhibits a high frequency of homozygous deletions and point mutations in established human tumor cell lines. |
|---|
References (references)
| References (references) | 1. Hunter, T. 1993. Cell 75: 839-841.
2. Sherr, C.J. 1993. Cell 73: 1059-1065. 3. El-Deiry, W.S., et al. 1993. Cell 75: 817-825. |
|---|